p 117: endocannabinoid system as a novel therapeutic target in epilepsy

نویسندگان

mohammad moein vakilzadeh student research committee, faculty of medicine, mashhad university of medical sciences, mashhad, iran

amirhossein heidari student research committee, faculty of medicine, mashhad university of medical sciences, mashhad, iran

ali mehri student research committee, faculty of medicine, mashhad university of medical sciences, mashhad, iran

sajad sahab negah department of neuroscience, mashhad university of medical sciences, mashhad, iran

چکیده

endocannabinoid (ecb) system plays a vital role in responses to stress. moreover, ecb and its receptors cause anti-inflammatory, anti-oxidative and neuroprotective effects by modulating neuronal, glial and endothelial cell functions. a number of studies have demonstrated ecb system notably defects in neurotraumatic and neurodegenerative diseases like epilepsy, tbi, alzheimer’s disease and parkinson’s disease. ecb system comprise of various compartments, including 2 g-protein-coupled receptors (gcpcrs), named cb1 and cb2 receptors, which create two pathways. most cannabinoid-based drugs used in treating neurodegenerative disorders affect cb1 pathway. activating cb2 moderate inflammatory response and stimulate the secretion of anti-inflammatory mediators in microglial cells and astrocytes. cb2 function increased in inflammatory condition in neuronal and endothelial cells, which limit neuroinflammation and blood-brain barrier disruption. in conclusion, involvements of ecb system in neurological disorders make it a suitable therapeutic target. in this review, we discussed the role of cb1 and cb2 receptors in neurodegenerative diseases. cb2 pathway is believed involved in inflammation response, but its relationship with epilepsy remains unclear. therefore, we suggest surveying the expression of cb2 receptor in an animal model of epilepsy.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

P 117: Endocannabinoid System as a Novel Therapeutic Target in Epilepsy

Endocannabinoid (ECB) system plays a vital role in responses to stress. Moreover, ECB and its receptors cause anti-inflammatory, anti-oxidative and neuroprotective effects by modulating neuronal, glial and endothelial cell functions. A number of studies have demonstrated ECB system notably defects in neurotraumatic and neurodegenerative diseases like epilepsy, TBI, Alzheimer’s disease and...

متن کامل

Endocannabinoid System as Novel Therapeutic Target for Autism Treatment

Dario Siniscalco1-3* 1Department of Experimental Medicine, Second University of Naples, Italy 2Centre for Autism – La Forza del Silenzio, Caserta, Italy 3Cancellautismo – No Profit Association for Autism Care, Florence, Italy *Corresponding author: Dario Siniscalco, Department of Experimental Medicine-Division of Pharmacology, Second University of Naples; via S. Maria di Costantinopoli, 16 8013...

متن کامل

P 86: CD166 as a Therapeutic Target in Autoimmune Diseases

About 3 decades ago CD6 identified as one of the first antigens expresses on the majority of T cells and a subset of B cells. CD6 regulates cellular adhesion migration across the endothelial and epithelial cells. In recent years researches indicate its role in pathogenesis of autoimmune diseases. Many researches have been done in recent years to block CD6 by CD6 mono clonal antibodies, IOR-T1 a...

متن کامل

The Endocannabinoid System as a Therapeutic Target in Glaucoma

Glaucoma is an irreversible blinding eye disease which produces progressive retinal ganglion cell (RGC) loss. Intraocular pressure (IOP) is currently the only modifiable risk factor, and lowering IOP results in reduced risk of progression of the disorder. The endocannabinoid system (ECS) has attracted considerable attention as a potential target for the treatment of glaucoma, largely due to the...

متن کامل

The Endocannabinoid System as a Therapeutic Target for Liver Diseases

Introduction Chronic liver disease is responsible for about 800,000 deaths a year due to cirrhosis and its complications. The most common causes of liver disease worldwide are viral hepatitis, chronic alcohol consumption, and non-alcoholic fatty liver disease (NAFLD) associated with the metabolic syndrome. All these conditions generate liver injury and inflammation, thereby activating liver fib...

متن کامل

p 86: cd166 as a therapeutic target in autoimmune diseases

about 3 decades ago cd6 identified as one of the first antigens expresses on the majority of t cells and a subset of b cells. cd6 regulates cellular adhesion migration across the endothelial and epithelial cells. in recent years researches indicate its role in pathogenesis of autoimmune diseases. many researches have been done in recent years to block cd6 by cd6 mono clonal antibodies, ior-t1 a...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
مجله علوم اعصاب شفای خاتم

جلد ۵، شماره ۲، صفحات ۱۴۸-۱۴۸

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023